A US judge has rejected the Federal Trade Commission’s attempt to block a deal between private equity firm Sycamore Partners and medical supply company Medline Industries. The deal, valued at $30 billion, would result in Medline being taken private by Sycamore. The FTC argued that the deal would harm competition in the medical supply industry.

Read more at Investing.com: US judge rejects FTC’s bid to block private equity medical company deal